SCHEMBL6537544

SCHEMBL6537544

COCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGES O14684 8/20 0.37
SLC16A3 O15427 1/20 0.36
GHSR Q92847 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 1/20 0.34
RIPK1 Q13546 2/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
JAK2 O60674 2/20 0.33
JAK1 P23458 2/20 0.33
TYK2 P29597 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537510 0.93 SLC16A3 (0.37) PTGESSLC16A3GHSRMEN1KMT2A
SCHEMBL6537404 0.92 SLC16A3 (0.36) PTGESSLC16A3GHSRMEN1KMT2A
SCHEMBL6537961 0.88 SLC16A3 (0.41) PTGESSLC16A3GHSRMEN1KMT2A
SCHEMBL6538571 0.88 SLC16A3 (0.38) PTGESSLC16A3GHSRMEN1KMT2A
SCHEMBL8471310 0.87 SLC16A3 (0.36) SLC16A3GHSRMEN1KMT2AHTT
SCHEMBL6537759 0.86 PTGES (0.44) PTGESSLC16A3GHSRMEN1KMT2A
SCHEMBL6537655 0.85 GHSR (0.34) PTGESSLC16A3GHSRMEN1KMT2A
SCHEMBL6537678 0.83 PTGES (0.42) PTGESSLC16A3MEN1KMT2APOLB
SCHEMBL6538012 0.83 PTGES (0.42) PTGESSLC16A3MEN1KMT2APOLB
SCHEMBL6538164 0.82 PTGES (0.43) PTGESSLC16A3GHSRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed